Avendus’s Healthcare practice leverages deep domain knowledge of pharma industry, healthcare providers and services, significant transaction and operating experience to provide strategic and corporate finance advice to a wide range of clients including growing businesses, large corporate houses and private equity funds. The group’s philosophy on every transaction revolves around senior team attention, hands-on approach and independent advice delivering best-in-class solutions to clients.
Our mergers and acquisitions (M&A) advisory and private equity (PE) syndication services are recognized as amongst the best in these chosen sub-sectors.
Chintan Kothari leads the Healthcare vertical for Avendus's investment banking business and is based in Mumbai.
He has an overall 15 years of experience in investment banking where he led healthcare and consumer vertical for Citigroup and prior to that for Rothschild India. Chintan has extensive transaction experience aggregating over USD 10 billion across pharmaceuticals (generics, injectables, branded generics, API and animal health) and healthcare sub-sectors (hospitals, diagnostics and single specialty). This covers a broad spectrum of transactions including both private and public markets. He has advised several large corporates including Pfizer, Sun Pharma, Lupin, Hindustan Unilever, United Spirits, Apollo Hospitals, Fortis, Dr. Lal Pathlabs, Metropolis as well as multiple mid-market family-owned businesses and several global private equity (PE) funds.
Chintan holds an MBA degree from Case Western Reserve University, USA and a Bachelor of Commerce degree from Sydenham College, Mumbai. He is a CFA charter holder.
Data and analytics are at the heart of digital transformation - the USD 27 billion offshore analytics market is expected to grow at 21.5% CAGR till 2025.
Read Time: 3 minutesIndia is going through one of its strongest funding cycles where founders are looking for more than just capital.
Read Time: 6 minutes.jpg)
Healthcare BPO has become a globally accepted model driven by several initiatives introduced by providers and payers. Attractive market opportunity, critical and counter-cyclic nature, tech-enabled transformation, high margins, and barriers to entry have led to premium valuation for healthcare BPO vendors.
The report gives an overview of the regulatory changes seen in the US Healthcare industry and its impact on IT/BPO segments. It also sheds light on the key drivers for outsourcing of IT healthcare services and the potential to outshore them to Indian players.
Connect with us on healthcare@avendus.com and we’ll get in touch with you.
.jpg){kind=spacer}
